New York State Common Retirement Fund Cabaletta Bio, Inc. Transaction History

New York State Common Retirement Fund

$74.9 Billion
Q3 2025

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 08, 2025	BUY	$3.94 - $8.24 $3,900 - $8,157	990 New	990 $4,000
Q3 2024 Oct 28, 2024	SELL	$3.94 - $8.24 $319,809 - $668,840	-81,170 Reduced 98.8%	990 $5,000
Q2 2024 Oct 08, 2025	BUY	$7.22 - $18.82 $593,195 - $1.55 Million	82,160 New	82,160 $614,000
Q2 2024 Jul 31, 2024	SELL	$7.22 - $18.82 $1,631 - $4,253	-226 Reduced 0.27%	82,160 $615,000
Q1 2024 Oct 08, 2025	BUY	$16.79 - $25.38 $1.38 Million - $2.09 Million	82,386 New	82,386 $1.41 Million

Q1 2024 May 07, 2024	BUY	$16.79 - $25.38 $960,304 - $1.45 Million	57,195 Added 227.05%	82,386 $1.41 Million
Q4 2023 Oct 08, 2025	BUY	$12.21 - $23.36 $307,582 - $588,461	25,191 New	25,191 $571,000
Q4 2023 Feb 01, 2024	BUY	$12.21 - $23.36 $181,049 - $346,382	14,828 Added 143.09%	25,191 $572,000
Q3 2023 Oct 08, 2025	BUY	$11.84 - $18.65 $122,697 - $193,269	10,363 New	10,363 $157,000
Q3 2023 Nov 07, 2023	BUY	$11.84 - $18.65 $4,297 - $6,769	363 Added 3.63%	10,363 $158,000
Q2 2023 Oct 08, 2025	BUY	$7.65 - $13.95 $76,500 - $139,500	10,000 New	10,000 $129,000
Q2 2023 Aug 07, 2023	BUY	$7.65 - $13.95 $76,500 - $139,500	10,000 New	10,000 $129,000
Q3 2021 Nov 02, 2021	SELL	$7.0 - $12.5 $714 - $1,275	-102 Closed	0 $0
Q2 2021 Aug 02, 2021	SELL	$7.2 - $11.73 $44,625 - $72,702	-6,198 Reduced 98.38%	102 $1,000
Q1 2021 May 11, 2021	SELL	$10.39 - $14.53 $71,691 - $100,257	-6,900 Reduced 52.27%	6,300 $70,000
Q2 2020 Aug 07, 2020	BUY	$6.39 - $11.28 $65,817 - $116,184	10,300 Added 355.17%	13,200 $147,000
Q1 2020 May 06, 2020	SELL	$6.0 - $18.67 $42,000 - $130,690	-7,000 Reduced 70.71%	2,900 $21,000
Q4 2019 Feb 05, 2020	BUY	$7.88 - $17.71 $78,012 - $175,329	9,900 New	9,900 $138,000

Others Institutions Holding CABA

# of Institutions

Shares Held

72.8M

Call Options Held

1.1M

Put Options Held

14.9K

Bain Capital Life Sciences Investors, LLC Boston, MA

9.68M
Shares

$22.4 Million
7.24% of portfolio
Adage Capital Partners Gp, L.L.C. Boston, MA

8.83M
Shares

$20.4 Million
0.03% of portfolio
Jennison Associates LLC

8.5M
Shares

$19.6 Million
0.01% of portfolio
T. Rowe Price Investment Management, Inc. Baltimore, MD

8.36M
Shares

$19.3 Million
0.01% of portfolio
Cormorant Asset Management, LP Boston, MA

5M
Shares

$11.6 Million
1.86% of portfolio

View Full List

About Cabaletta Bio, Inc.

Ticker CABA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 29,014,000
Market Cap $67M
Description
Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of engineered T cell therapies for patients with B cell-mediated autoimmune diseases. Its proprietary technology utilizes chimeric autoantibody receptor (CAAR) T cells that are designed to selectively bind and eliminate B cells, which produce di...

More about CABA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

News

Stay updated on New York State Common Retirement Fund with notifications on news.

Account